Forest lands Furiex and expands GI business in $1.5B buyout deal

John Carroll

has landed its big . After nabbing promising late-stage data on a new drug for irritable bowel syndrome and virtually slapping a "for sale" sign on the company, Labs has swooped in to buy the biotech company for $ 1.1 billion and potentially $ 360 million in contingent value rights.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS